0.5017
price down icon5.38%   -0.0285
after-market After Hours: .53 0.0283 +5.64%
loading
Century Therapeutics Inc stock is traded at $0.5017, with a volume of 639.49K. It is down -5.38% in the last 24 hours and down -9.57% over the past month. Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
See More
Previous Close:
$0.5302
Open:
$0.5273
24h Volume:
639.49K
Relative Volume:
1.21
Market Cap:
$46.53M
Revenue:
$2.24M
Net Income/Loss:
$-136.67M
P/E Ratio:
-0.2191
EPS:
-2.29
Net Cash Flow:
$-102.08M
1W Performance:
-7.72%
1M Performance:
-9.57%
6M Performance:
-63.91%
1Y Performance:
-84.07%
1-Day Range:
Value
$0.498
$0.5273
1-Week Range:
Value
$0.498
$0.57
52-Week Range:
Value
$0.3418
$3.70

Century Therapeutics Inc Stock (IPSC) Company Profile

Name
Name
Century Therapeutics Inc
Name
Phone
215-981-4000
Name
Address
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Name
Employee
165
Name
Twitter
Name
Next Earnings Date
2025-03-19
Name
Latest SEC Filings
Name
IPSC's Discussions on Twitter

Compare IPSC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IPSC
Century Therapeutics Inc
0.5017 46.53M 2.24M -136.67M -102.08M -2.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-08-24 Initiated Rodman & Renshaw Buy
Aug-28-23 Downgrade JP Morgan Overweight → Neutral
Dec-27-22 Initiated Chardan Capital Markets Buy
Oct-31-22 Initiated Guggenheim Buy
Oct-10-22 Initiated Canaccord Genuity Buy
May-23-22 Initiated H.C. Wainwright Buy
May-12-22 Initiated William Blair Mkt Perform
Jul-13-21 Initiated BofA Securities Buy
Jul-13-21 Initiated JP Morgan Overweight
Jul-13-21 Initiated Piper Sandler Overweight
View All

Century Therapeutics Inc Stock (IPSC) Latest News

pulisher
Apr 24, 2025

Is it possible to buy Century Therapeutics Inc(IPSC) shares at a good price now? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Century Therapeutics Inc (IPSC): A Sitting Duck With -825.93% Upside Potential - Stocksregister

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains Buy rating on Century Therapeutics stock - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Century Therapeutics Inc (IPSC)’s financial ratios: A comprehensive overview - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains Buy rating on Century Therapeutics stock By Investing.com - Investing.com UK

Apr 24, 2025
pulisher
Apr 23, 2025

Century Therapeutics Inc [IPSC] Stock sold by Insider Pfeiffenberger Brent for $1375.0 - knoxdaily.com

Apr 23, 2025
pulisher
Apr 20, 2025

Century Therapeutics Hosts Live Fireside Chat on Groundbreaking Cell Therapy Advances - MSN

Apr 20, 2025
pulisher
Apr 15, 2025

Century Therapeutics to Host Live Chat on Preclinical Cell Therapy Programs Targeting Autoimmune Diseases and Cancer - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

Century Therapeutics to Host Live Fireside Chat Focused on - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

Century Therapeutics Unveils Next-Gen Cell Therapy Pipeline for Cancer and Autoimmune | IPSC Stock News - Stock Titan

Apr 15, 2025
pulisher
Apr 15, 2025

American Century Companies Inc. Buys Shares of 105,337 Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Buys 24,153 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Purchases 12,162 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Invests $231,000 in Summit Therapeutics Inc. (NASDAQ:SMMT) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Purchases New Stake in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Invests $570,000 in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Boosts Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Invests $474,000 in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Acquires 4,547 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Purchases 13,916 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Has $696,000 Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Bought by American Century Companies Inc. - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Purchased by American Century Companies Inc. - Defense World

Apr 11, 2025
pulisher
Apr 08, 2025

American Century Companies Inc. Buys 24,090 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

HC Wainwright Issues Positive Forecast for IPSC Earnings - Defense World

Apr 07, 2025
pulisher
Apr 07, 2025

American Century Companies Inc. Acquires 39,932 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World

Apr 07, 2025
pulisher
Apr 07, 2025

American Century Companies Inc. Has $3.36 Million Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM) - Defense World

Apr 07, 2025
pulisher
Apr 06, 2025

American Century Companies Inc. Buys 1,622 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Apr 06, 2025
pulisher
Apr 05, 2025

Century Therapeutics Partners with Experts for New Trial on Autoimmune Diseases - MSN

Apr 05, 2025
pulisher
Apr 05, 2025

American Century Companies Inc. Purchases 31,251 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

HC Wainwright Issues Pessimistic Forecast for Century Therapeutics (NASDAQ:IPSC) Stock Price - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

H.C. Wainwright cuts Century Therapeutics target to $2 By Investing.com - Investing.com Canada

Apr 03, 2025
pulisher
Apr 03, 2025

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Shares Sold by American Century Companies Inc. - Defense World

Apr 03, 2025
pulisher
Apr 03, 2025

American Century Companies Inc. Raises Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by American Century Companies Inc. - Defense World

Apr 02, 2025
pulisher
Mar 30, 2025

Guggenheim Reiterates Buy Rating for Century Therapeutics (NASDAQ:IPSC) - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

What is Chardan Capital’s Estimate for IPSC FY2025 Earnings? - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

Century Therapeutics (IPSC) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

Century Therapeutics (NASDAQ:IPSC) Price Target Lowered to $7.00 at Chardan Capital - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

William Blair Issues Optimistic Forecast for IPSC Earnings - The AM Reporter

Mar 25, 2025
pulisher
Mar 24, 2025

Carnival To Rally Around 48%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Mar 24, 2025
pulisher
Mar 24, 2025

Q1 EPS Estimate for Century Therapeutics Boosted by Analyst - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

Chardan Cuts Price Target on Century Therapeutics to $7 From $11, Keeps Buy Rating - MarketScreener

Mar 24, 2025
pulisher
Mar 23, 2025

Century Therapeutics Announces Strategic Pipeline Shift and 2024 Financial Results - MSN

Mar 23, 2025
pulisher
Mar 23, 2025

Guggenheim Lowers Century Therapeutics (NASDAQ:IPSC) Price Target to $5.00 - Defense World

Mar 23, 2025
pulisher
Mar 23, 2025

Piper Sandler Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $2.00 - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Guggenheim cuts Century Therapeutics target to $5, keeps Buy rating By Investing.com - Investing.com Canada

Mar 22, 2025
pulisher
Mar 22, 2025

What is William Blair’s Estimate for IPSC Q3 Earnings? - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Demystifying Century Therapeutics: Insights From 4 Analyst Reviews - Benzinga

Mar 21, 2025
pulisher
Mar 20, 2025

Century Therapeutics Reports 2024 Financial Results and Strategic Updates - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Leerink Partners Adjusts Price Target on Century Therapeutics to $8 From $13, Keeps Outperform Rating - Marketscreener.com

Mar 20, 2025

Century Therapeutics Inc Stock (IPSC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Cap:     |  Volume (24h):